Autoimmune Disease Diagnostics Market Worth $7.53 Billion by 2029 - Exclusive Report by Meticulous Research®
15 déc. 2022 10h00 HE
|
Meticulous Market Research Pvt. Ltd.
Redding, California, Dec. 15, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled, ‘Autoimmune Disease Diagnostics Market by Product (Reagents, Kits, Assays, Instruments),...
Autoimmune Disease Diagnostics Market Size Worth USD 7.2 Billion by 2030 at 6.7% CAGR – Report by Market Research Future (MRFR)
20 oct. 2022 11h30 HE
|
Market Research Future
New York, USA, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Autoimmune Disease Diagnostics Market Overview: According to a Comprehensive Research Report by Market Research Future (MRFR), “Autoimmune...
Exagen Announces Appointment of Andrew L. Concoff MD, FACR, CAQSM, as Chief Innovation Officer
04 oct. 2022 08h25 HE
|
Exagen Inc.
SAN DIEGO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced the appointment of Andrew L. Concoff M.D. FACR, CAQSM as...
Exagen Announces Acceptance of Multiple Abstracts at ACR 2022 Annual Meeting
20 sept. 2022 16h05 HE
|
Exagen Inc.
SAN DIEGO, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today the acceptance of nine abstracts at the 2022 American...
Exagen Inc. Collaboration Leads to Characterization of Broad Autoreactivity in Severe COVID-19 Patients
01 sept. 2022 16h05 HE
|
Exagen Inc.
SAN DIEGO, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that its collaboration with Dr. Iñaki Sanz at Emory...
Allsup Supports “Walk To End Lupus Now 2022” with LFA Heartland Chapter On Saturday, Sept. 10
31 août 2022 14h12 HE
|
Allsup
Belleville, Illinois, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Allsup, the nation’s premier disability representation company®, is proud to be sponsoring the “Walk To End Lupus Now 2022-St. Louis”...
Horizon Therapeutics Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Horizon Therapeutics Plc
03 août 2022 15h58 HE
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Horizon Therapeutics plc ("Horizon Therapeutics” or...
Exagen Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference
25 juil. 2022 16h05 HE
|
Exagen Inc.
SAN DIEGO, July 25, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the Canaccord Genuity 42nd Annual...
Clinical Trials Market worth 81.6 billion by 2030, says Global Market Insights Inc.
13 juin 2022 06h15 HE
|
Global Market Insights Inc.
Selbyville, Delaware , June 13, 2022 (GLOBE NEWSWIRE) -- The clinical trials market value is expected to reach USD 81.6 billion by 2030, according to a new research report by Global Market...
ZEUS Scientific Announces FDA Clearance for the ZEUS dIFine® IFA Imaging and Pattern Recognition System
03 mai 2022 08h00 HE
|
ZEUS Scientific
BRANCHBURG, N.J., May 03, 2022 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration (FDA) has cleared ZEUS Scientific's dIFine® digital immunofluorescence system* for use with ZEUS' ANA HEp-2...